Alphapharm Drops Antitrust Claims In Treximet IP Suit
Alphapharm Pty. Ltd. has agreed to drop antitrust counterclaims against Pozen Inc., though the battle rages on over whether it and several other generics makers infringed Pozen's patents for migraine treatment...To view the full article, register now.
Already a subscriber? Click here to view full article